Trevi Therapeutics, Inc.

Contributing Author

Recent Articles by Trevi Therapeutics, Inc.

Mar-17	Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates TRVI GlobeNewswire
Mar-10	Trevi Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results and Provide Business Updates on March 17, 2026 TRVI GlobeNewswire
Mar-09	Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough TRVI -12.03% GlobeNewswire
Mar-02	Trevi Therapeutics to Participate in Upcoming March Conferences TRVI +5.45% GlobeNewswire
Feb-17	Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference TRVI GlobeNewswire